Proteos, Inc.

Kalamzoo, MI 49008

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.66MM
First Award Date 09/30/05
Most Recent Award Date 09/01/11

Key Personnel

Last Name Name Awards Contact
Heinrikson Robert Heinrikson 2
Donahue Seth Warner Donahue 3

5 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 09/01/11 - 08/31/13

DESCRIPTION (provided by applicant): Project Summary/Abstract. A clinical need exists for better osteoporosis treatments since only one anabolic therapy (truncated recombinant human parathyroid hormone 1-34, teriparatide/Forteo(R)) is commercially available. Bears possess the unique ability to prevent bone loss during physical inactivity (hibern...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-09-081
Budget: 09/25/10 - 08/31/11

DESCRIPTION (provided by applicant): Project Summary/Abstract. A clinical need exists for better osteoporosis treatments since only one anabolic therapy (truncated recombinant human parathyroid hormone 1-34, teriparatide/Forteo(R)) is commercially available. Bears possess the unique ability to prevent bone loss during physical inactivity (hibern...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-OD-09-009
Budget: 07/15/10 - 02/29/12

DESCRIPTION (provided by applicant): Project Summary/Abstract: The efficacy of injected therapeutic proteins is often compromised by their rapid clearance from the circulation. This means that doses must be administered more often, impacting both patient compliance and cost of treatment. A major search is underway in academic and industrial labo...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-07-81
Budget: 07/10/08 - 06/30/10

DESCRIPTION (provided by applicant): A clinical need exists for better osteoporosis treatments since only one anabolic therapy (recombinant human parathyroid hormone) is commercially available. Bears are uniquely able to prevent bone loss during physical inactivity (hibernation) by maintaining balanced bone remodeling; the biological processes ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/05 - 02/28/07

DESCRIPTION (provided by applicant): The goal of this Phase 1 proposal is to optimize the activity and minimize the size of a protein therapeutic for intestinal bowel diseases (IBD), in order to enable production of the protein in quantities needed for trials in humans. Currently, there is no safe and effective treatment for IBD. Professor Samue...